X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 51 filers reported holding X4 PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $708,500 | -43.8% | 650,000 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $1,261,000 | +123.0% | 650,000 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $565,500 | -12.4% | 650,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $645,450 | -85.2% | 650,000 | -74.5% | 0.00% | -88.2% |
| Q3 2022 | $4,354,000 | +176.3% | 2,546,446 | +55.9% | 0.02% | +142.9% |
| Q2 2022 | $1,576,000 | -44.9% | 1,633,204 | 0.0% | 0.01% | -36.4% |
| Q1 2022 | $2,858,000 | -23.6% | 1,633,204 | 0.0% | 0.01% | -26.7% |
| Q4 2021 | $3,740,000 | – | 1,633,204 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,682,000 | 3.48% |
| Sio Capital Management, LLC | 804,597 | $6,928,000 | 1.41% |
| Bain Capital Life Sciences Investors, LLC | 2,119,540 | $18,249,000 | 1.03% |
| SV Health Investors, LLC | 311,490 | $2,682,000 | 1.00% |
| Monashee Investment Management LLC | 574,712 | $4,948,000 | 0.76% |
| Ikarian Capital, LLC | 2,614,988 | $22,515,000 | 0.76% |
| Abingworth LLP | 229,885 | $1,956,000 | 0.68% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,884,000 | 0.67% |
| BVF INC/IL | 1,091,579 | $9,398,000 | 0.35% |
| Endurant Capital Management LP | 151,996 | $1,309,000 | 0.34% |